We are developing a catalogue of products based on our trademarked biomaterial solution, BiomimInks.
Our proprietary materials and technology integrated with our materials are designed to help “re-boot” the body’s natural bioelectric current to promote tissue healing whilst presenting antimicrobial properties.
3D printability of our biomaterials enables us to offer bespoke solutions to address a range of diseased and damaged tissue.
A person has a better chance of living five years with breast, prostate or colon cancer than a diabetic with a foot ulcer.
Guest et al; Cohort study evaluating the burden of wounds to the UK’s National Health Service in 2017/2018; doi: 10.1136/bmjopen-2020-045253
Founder of NuTissu with 10+ years of experience following her doctorate, has been executing projects in surgical MedTech and related. She brings a unique approach to solving wounds combining biomaterials, bioelectricity and digital health technology.
Stephen Carter is Founder of The Intellectual Property Works, an intellectual property consultancy. He is a UK and European Patent Attorney with over 25 years’ experience and is recognised by IAM300 as a leading IP strategist. Having spent many years as a partner in two London-based law firms, Stephen now acts as an advisor to innovative start-ups and SMEs.
Steven Jeffery is a Consultant Burns and Plastic Surgeon and is Professor of Wound Study and Birmingham City University. He has extensive experience of complex wound management and is also an Internal Clinician for BSI.
Karen is a solicitor, founder and managing director of a City Law Firm and brings a wealth of experience to secure legal and business terms to maximise the commercial value of NuTissu.
Minister for Veterans’ Affairs Johnny Mercer joined with Nutissu staff to announce Veterans Health Innovation Fund awards aiming to improve the UK’s capability to save
Abstract: Hollow, tubular organs including oesophagus, trachea, stomach, intestine, bladder and urethra may require repair or replacement due to disease. Current treatment is considered an
There is an unmet need for artificial tissue to address current limitations with donor organs and problems with donor site morbidity. Despite the success with
A Senior Electronics Engineer (with Medical Device/IoT go-to market experience).
A Formulation/Polymer Chemist with Experience in Market/Business Development.